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The effect of alcohol on atherosclerotic plaque
composition and cardiovascular events in patients
with arterial occlusive disease
Suzanne S. Gisbertz, MD,a Wouter J. M. Derksen, MD,b Dominique P. V. de Kleijn, PhD,b
Aryan Vink, MD, PhD,c Michiel L. Bots, MD, PhD,d Jean-Paul P. M. de Vries, MD, PhD,a
Frans L. Moll, MD, PhD,e and Gerard Pasterkamp, MD, PhD,b Nieuwegein and Utrecht, The Netherlands
Objectives: This study examined the association between alcohol use, the occurrence of cardiovascular events, and plaque
phenotype in patients after femoral or carotid endarterectomy for arterial occlusive disease. Alcohol has been shown to
have cardiovascular protective effects in patients with cardiovascular disease as well as in healthy individuals. Whether
alcohol consumption induces changes in atherosclerotic plaque composition has not been investigated.
Methods: Consecutive femoral (n  224) and carotid (n  693) endarterectomy specimens underwent histologic
examination for the presence of collagen, calcifications, smoothmuscle cells, macrophages, fat, and intraplaque thrombus.
Patients weremonitored for 3 years after the initial operation and investigated for the occurrence of cardiovascular events.
Primary outcome was the composite end point “major cardiovascular event.” Alcohol consumption was categorized as no
alcohol use, 1 to 10 U/wk, or >10 U/wk.
Results: The Kaplan-Meier estimate of the major cardiovascular event rate after 3 years of follow-up in the femoral group
was 35% for no alcohol use and 21% for 1 to 10 U/wk, whereas only 10% of the group >10 U/wk sustained a major
cardiovascular event (P  .010). The plaques of alcohol consumers in the femoral group contained significantly smaller
lipid cores and less macrophage infiltration than in abstainers. In the carotid group, the major cardiovascular event rate
was similar in all three groups, and in addition, no difference in plaque composition was observed.
Conclusions: This study shows an inverse relationship between alcohol use and major cardiovascular events after
endarterectomy for lower extremity arterial occlusive disease, accompanied by a more stable plaque phenotype. However,
no such relationship could be observed for patients with cerebrovascular disease. ( J Vasc Surg 2011;54:123-32.)
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bModerate alcohol consumption (10 to 20 U/wk) has
been consistently associated with a lower risk for myocar-
dial infarction, stroke, peripheral arterial occlusive disease,
and type 2 diabetes.1-11 In addition to a beneficial effect in
patients with known coronary heart disease, a cardioprotec-
tive effect of alcohol has been demonstrated in healthy
individuals.1,2,6-10
The mechanisms behind the cardiovascular protective
effects of alcohol are not fully understood but are thought
to be attributable to an anti-inflammatory effect on low-
grade inflammatory diseases such as atherosclerosis.12,13
Alcohol consumption changes the lipid profile, including
increases in high-density lipoprotein cholesterol.14,15 Alco-
hol also affects thrombus formation by inhibitory effects on
platelet aggregation and function combined with increased
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doi:10.1016/j.jvs.2010.12.039brinolytic activity and lower fibrinogen levels.16-18 More-
ver, alcohol influences antioxidant capacity and insulin
ensitivity, thus restraining atherosclerosis.5,16,19
Atherosclerosis is a generalized condition and is there-
ore associated with an increased risk of secondary cardio-
ascular events when a primary symptomatic lesion has
een diagnosed. Whether patients with clinical presenta-
ion of lower extremity arterial occlusive disease or cerebro-
ascular disease would benefit from the beneficial effects of
lcohol consumption remains unknown. Whether alcohol
se is associated with plaque composition is also unknown.
he objective of this study was to investigate the association
etween alcohol intake, cardiovascular events, and plaque
haracteristics in patients undergoing femoral or carotid
ndarterectomy.
ETHODS
The Medical Ethics Boards of the participating hospi-
als approved the study, and all patients provided written
nformed consent.
Study design of the Athero-Express Biobank. The
esign of the Athero-Express study has been reported in
etail previously.20 Inclusion for the current substudy was
etween April 2002 and March 2007. Included were sub-
equent patients undergoing (1) remote superficial femoral
rtery endarterectomy or endarterectomy of the femoral
ifurcation with or without additional bypass graft for
evere intermittent claudication, critical ischemia, or tissue
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July 2011124 Gisbertz et alloss (Rutherford category 2 to 5)21 with atherosclerotic
lesions (TransAtlantic Intersociety Consensus [TASC] A to
D)22 of the femoral artery, and (2) patients undergoing
carotid endarterectomy for symptomatic carotid artery ste-
nosis with 70% lumen diameter reduction.
Clinical parameters were recorded at baseline. Patients
completed a detailed validated questionnaire, including
alcohol consumption habits,20 based on the validated Rose
questionnaire.23 For the assessment of alcohol intake, a
quantity–frequency method was used.24 Alcohol consump-
tion was a priori categorized as no alcohol use, 1 to 10
U/wk, or 10 U/wk. The subgroup of patients consum-
ing20 U/wk could not be analyzed separately because it
was too small and was underpowered to perform statistical
analysis. One unit was defined as 12 grams of alcohol.
Subgroup analyses were not performed by type of beverage
due to lack of such detailed information.
Atherosclerotic plaque characterization. The ath-
erosclerotic plaques excised during surgery were directly
processed in the laboratory for histologic examination. The
plaques were evaluated for the presence of collagen, calci-
fications, smooth muscle cells, macrophages, fat, and
thrombus, as described previously, and independent of
knowledge on alcohol consumption.20 The plaque was
divided in 5-mm-thick segments along the longitudinal
axis. The segment with the greatest plaque burden was
subjected to histologic examination. The plaque morphol-
ogy of this segment has been shown to be relatively good
representative and uniform from within each individual.25
Comparison of the histologic scorings of adjacent seg-
ments revealed a mean  (weighted ) of 0.40 (range,
0.33-0.60). When the culprit segment was compared with
the more distant segment, the mean  was 0.24; however,
the difference between the culprit segment and the distal
segment was one category or less in 91% of cases.25
Macrophage infiltration (CD-68), smooth muscle cell
infiltration (-actin), the amount of collagen (Picrosirius
red), and calcification (hematoxylin and eosin) were semi-
quantitatively scored as (1) none or minor, or (2) moderate
or heavy staining. The criteria for classification were defined
as follows: for macrophages: (1) absent or minor CD-68
staining with negative or few scattered cells, or (2) moder-
ate or heavy staining, defined as clusters of cells with 10
cells present; for smooth muscle cells: (1) minor -actin
staining over the entire circumference with absent staining
at parts of the circumference of the arterial wall, or (2)
positive cells along the entire circumference of the luminal
border; and for collagen staining: (1) none or minor stain-
ing along part of the luminal border of the plaque, or (2)
moderate or heavy staining along the entire luminal border.
Luminal thrombus and intraplaque bleeding were ex-
amined in hematoxylin and eosin and fibrin stainings (Mal-
lory staining) and rated as being absent or present. The size
of the lipid core was visually estimated as the percentage of
total plaque area using hematoxylin and eosin and Picro-
sirius red stainings, with a division in two categories of
10% and 10%. The histologic examination was per-
formed by two independent observers who were blinded wor the clinical data. The intraobserver and interobserver
emiquantitative analysis of atherosclerotic plaque histol-
gy is well reproducible.25 CD-68 and -actin stainings
ere scored as the percentage of the plaque area using
nalySIS 3.0 software (Olympus, Tokyo, Japan). This
omputerized analysis revealed an excellent correlation
ith the semiquantitative observations.
The  values (weighted kappa) for intraobserver vari-
bility of fat, macrophages, smooth muscle cells, collagen,
alcifications, thrombus, and overall phenotype were 0.83,
.85, 0.71, 0.63, 0.81, 0.80, and 0.86, respectively, and 
alues for interobserver variability were 0.68, 0.74, 0.54,
.59, 0.82, 0.75, and 0.71, respectively.25 The difference
n  value between collagen and the other stains was un-
ubstantial. The Picrosirius red stains are relatively easy to
nalyze due to good discrimination between areas that are
es/no stained. In addition, collagen often covers a broad
ercentage of the total plaque area, which is somewhat
ifferent for cellular stainings that are expressed for a low
ercentage of total plaque area.
Follow-up. Surgical intervention in atherosclerotic
isease is a sign of disease progression to a severe extent,
ith a poor prognosis. Patients diagnosed with critical limb
schemia have a 25% mortality rate the first year after
resentation due to fatal cardiovascular events.22 Accord-
ngly, most events will occur within the first years after
urgery. The follow-up of the Athero-Express trial is there-
ore limited to 3 years, and all patients in this article were
onitored for at least 1 year after the operation.
Once a year, patients were asked to complete a ques-
ionnaire during the follow-up for 3 years after the initial
urgery. The questionnaire inquired about cardiovascular
vents and hospitalization in the past year. The general
ractitioner was contacted when patients did not respond.
linical end points included incidence of cardiovascular
nd cerebrovascular death, myocardial infarction, coronary
rtery bypass graft operation, coronary angioplasty, and
troke. When patients revealed an event during follow-up,
he correct diagnosis was obtained from discharge sum-
aries and medical records. Two vascular surgeons from
ifferent institutions who were blinded for each other’s
udgment validated cardiovascular events by separately
eviewing medical records.
The primary outcome was a composite end point “ma-
or cardiovascular event” and included cardiovascular and
erebrovascular death, myocardial infarction, coronary ar-
ery bypass grafting, coronary angioplasty, and stroke. Sec-
ndary end points were cardiovascular death and a compos-
te end point “all cardiovascular events,” including major
ardiovascular events and death, as described previously,
ransient ischemic attacks, and peripheral interventions,
ncluding peripheral bypasses or desobstruction proce-
ures, aneurysm rupture and repair, renal artery proce-
ures, and leg amputation.
Data analysis. Statistical analysis was performed with
PSS 15.0 software (SPSS Inc, Chicago, Ill). Event rates
the primary and secondary end points) were calculated
ith Kaplan-Meier life-table estimates in the two cohorts
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Volume 54, Number 1 Gisbertz et al 125separately. Being interested in the effect on the primary end
point (major cardiovascular events) of alcohol consump-
tion only, we used multivariate Cox proportional hazard
regressionmodels to adjust for possible confounders. Every
baseline characteristic (Table I) was entered first in the
univariate analyses. Only if a baseline characteristic showed
an association (P .1) with the primary end point was this
characteristic entered as covariate in multivariate analysis.
Univariate and multivariate analysis was performed in the
two cohorts separately. Age and sex were included in all
multivariate models. Rutherford classification and ankle-
brachial index were included in multivariate models of the
femoral cohort. Results are presented as hazard ratios with
the exact 95% confidence interval (CI). A log-rank test,
Mann-WhitneyU test, 2 test, or Spearman correlation was
used as indicated to compare both groups. A value of P 
.05 was considered statistically significant. The relation
with plaque characteristics was studied in a similar manner,
using univariable and multivariate models. The latter in-
cluded adjustments for age, gender, smoking history, dia-
betes, and body mass index.
RESULTS
A total of 1167 consecutive patients in the Athero-
Express Biobank were monitored for a minimum of 1 year
postoperatively and were assessed for eligibility (Fig 1).
Owing to malignant disease, permanent extramural care, or
lack of informed consent, 23 of 302 patients in the femoral
group and 51 of 865 patients in the carotid group were
excluded. An additional 52 patients in the femoral group
and 116 patients in the carotid group were excluded be-
cause information on alcohol use was lacking or plaque
Fig 1. Enrolmaterial was insufficient. Three patients in the femoral mroup and five patients in the carotid group were lost to
ollow-up. The final analysis therefore included 224 pa-
ients operated on for lower extremity arterial occlusive
isease and 693 patients operated on for cerebrovascular
isease.
Baseline characteristics of the study population are
ummarized in Table I, A and B. In both study groups,
atients abstaining from alcohol were significantly older
han patients consuming alcohol. Furthermore, signifi-
antly more men and more former or current smokers were
mong the alcohol users in the femoral and carotid groups.
n the carotid study population, more patients abstaining
rom alcohol reported a history of coronary artery disease.
ll shown differences between patients abstaining from
lcohol and patients consuming alcohol were linear dose-
ependent. During follow-up, we observed 35 major car-
iovascular events in the femoral cohort and 86 major
ardiovascular events in the carotid cohort.
Plaque characteristics in relation to alcohol consump-
ion for both study groups are presented in Table II.
laques of the femoral study population revealed larger
ipid cores and more macrophage infiltration in patients
bstaining from alcohol than in patients consuming alco-
ol, with a dose–response relationship: 47% of the plaques
n the no-alcohol group had a lipid core 10% vs 28% for
he 1 to 10U/wk group and 19% for the10U/wk group
P  .002). In the no-alcohol group, 33% of the plaques
howed moderate or heavy macrophage infiltration vs 26%
n the 1 to 10 U/wk group and 17% for10 U/wk group
P  .033). This relationship was not observed in the
arotid study population. Multivariate analyses did not
how materially different results in statistical significance or
t of patients.agnitude of the associations.
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alcohol had significantly more major cardiovascular events
than those who consumed alcohol after a mean follow-up
of 25 months. The Kaplan-Meier estimate of event rate
after 3 years of follow-up was 35% for no alcohol and 21%
for 1 to 10 U/wk, whereas only 10% of the 10 U/wk
group had sustained a major cardiovascular event (univari-
ate P  .010; Fig 2, A; Table III, A). The Kaplan-Meier
estimate of event rate after 3 years of follow-up in the
carotid group was 11% for no alcohol, 15% for 1 to 10
U/wk, and 17% for10U/wk (univariate P .618; Fig 2,
B; Table III, B). Adjustment for imbalance in baseline
characteristics by use of Cox hazard regression analysis did
not alter these results.
The Kaplan-Meier estimate for cardiovascular death
rate in the femoral group was 20% for no alcohol, 14% for 1
to 10 U/wk, and 3% for10 U/wk at 3 years of follow-up
(univariate P  .036), and total mortality in the femoral
cohort (n  24) was 25%, 16%, and 3%, respectively (uni-
variate P  .007). In the carotid group, no significant
difference was noted in the cardiovascular death rate: 7% for
no alcohol, 5% for 1 to 10 U/wk, and 3% for 10 U/wk
Table I. A, Clinical characteristics of the study population
None
Variablea (n  45)
Age, y 69 (48-81)
Sex
Female 17 (37.8)
Male 28 (62.2)
BMI, mean (SD) kg/m2 26 (3.6)
Current smoker 19 (43.2)
History of smokingb 41 (93.2)
Diabetes 9 (20.5)
Hypertension 32 (71.1)
Hypercholesterolemia 33 (75.0)
History of
Coronary artery disease 21 (46.7)
Cerebrovascular disease 22 (48.9)
Peripheral artery disease 43 (95.6)
Indication for operation
Rutherford category III 33 (73.7)
Rutherford category IV 10 (22.2)
Rutherford category V 2 (4.4)
TASC classification
AB 14 (31.8)
C–D 30 (68.2)
ABIc, mean (SD) 0.60 (0.16)
Creatinine, mean (SD), mg/dL 120 (86)
HDL, mean (SD), mmol/L 1.08 (0.40)
LDL, mean (SD), mmol/L 2.76 (0.98)
Statin use 37 (82.2)
Aspirin use 36 (80.0)
Oral anticoagulant use 12 (26.7)
Duration of alcohol use, y
Duration of abstention, y 16 (10-38)
ABI,Ankle-brachial index;BMI, bodymass index;HDL, high-density lipopro
aData are presented as number (%) or as mean (range), unless otherwise ind
bIncluding current smoking.
cCalculated as blood pressure at ankle level divided by blood pressure at arm(univariate P .235). Total mortality in the carotid cohort fn  44) was 10%, 7% and 5%, respectively (univariate P 
281). The event rate for all cardiovascular events by
aplan-Meier life-table analysis in the femoral group was
0% for no alcohol, 57% for 1 to 10 U/wk, and 53% for
10 U/wk (univariate P .182) and in the carotid group
as 21% for no alcohol, 26% for 1 to 10U/wk, and 29% for
10 U/wk (univariate P  .343).
In the femoral group, with 35 events, univariate analy-
is showed that age was associated with an increased risk for
ajor cardiovascular events, with a hazard ratio of 1.04 per
ear of age (95% CI, 1.00-1.08; P  .039). Other baseline
haracteristics were not significantly associated with an
ltered risk for cardiovascular events. In multivariate Cox
azard regression analysis, with adjustments for age, gen-
er, smoking, diabetes and body mass index, only alcohol
onsumption remained independently associated with a
ecreased risk for major cardiovascular events, with a haz-
rd ratio of 0.52 (95% CI, 0.33-0.81; P .004; Table IV).
ISCUSSION
This study describes the effects of alcohol consumption
n relation to plaque characteristics on the occurrence of
elation to alcohol consumption
1-10 U/wk 10 U/wk
(n  86) (n  93) P
65 (44-87) 65 (48-84) .004
25 (29.1) 13 (14.0) .001
61 (70.9) 80 (86.0)
26 (3.4) 25 (3.8) .364
29 (33.7) 32 (34.4) .441
82 (95.3) 92 (100) .019
19 (22.1) 28 (30.8) .133
58 (67.4) 63 (67.7) .758
59 (71.1) 64 (68.8) .473
32 (37.2) 33 (35.5) .268
24 (27.9) 33 (35.5) .373
82 (95.3) 89 (95.7) .944
68 (79.1) 67 (72.0) .423
12 (14.0) 15 (16.1)
6 (7.0) 11 (11.8)
30 (34.9) 29 (31.9) .887
56 (65.1) 62 (68.1)
0.58 (0.17) 0.59 (0.19) .520
100 (44) 95 (30) .185
1.05 (0.29) 1.16 (0.46) .692
2.52 (0.88) 2.56 (0.97) .799
63 (73.3) 69 (74.2) .433
69 (80.2) 75 (80.6) .923
22 (25.6) 21 (22.6) .559
44 (19-63) 48 (7-61) .036
LDL, low-density lipoprotein;TASC,TransAtlantic Intersociety Consensus.
.
(mm Hg).in r
tein;
icateduture cardiovascular events in patients operated on for
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Volume 54, Number 1 Gisbertz et al 127Table I. B, Clinical characteristics of the carotid study population in relation to alcohol consumption
None 1-10 U/wk 10 U/wk
Variablea (n  210) (n  304) (n  186) P
Age, y 68 (37-88) 67 (43-90) 65 (44-89) .001
Sex
Female 100 (48.1) 75 (24.9) 28 (15.2) .001
Male 108 (51.9) 226 (75.1) 156 (84.8)
BMI, mean (SD) kg/m2 27 (3.9) 26 (3.8) 27 (3.4) .186
Current smoker 58 (28.3) 70 (23.3) 54 (29.5) .853
History of smokingb 154 (75.1) 270 (90.9) 168 (91.8) .001
Diabetes 48 (23.6) 65 (21.8) 36 (20.2) .420
Hypertension 150 (73.5) 214 (72.3) 143 (78.6) .283
Hypercholesterolemia 130 (65.0) 191 (65.9) 127 (70.6) .261
History of
Coronary artery disease 76 (36.5) 100 (33.2) 46 (25.0) .016
Cerebrovascular disease 204 (98.1) 299 (99.3) 180 (97.8) .902
Peripheral artery disease 46 (22.1) 88 (29.2) 38 (20.7) .840
Duplex stenosis .561
50%-64% 5 (2.4) 11 (3.7) 6 (3.3)
65%-89% 83 (40.5) 130 (43.3) 79 (43.9)
90%-100% 117 (57.1) 159 (53.0) 95 (52.8)
Clinical presentation .304
Symptomatic 168 (80.8) 256 (85) 147 (80.3)
Asymptomatic 40 (19.2) 45 (15) 36 (19.7)
Creatinine, mean (SD), mg/dL 90 (30) 103 (55) 98 (30) .106
HDL, mean (SD), mmol/L 1.12 (0.33) 1.15 (0.35) 1.22 (0.41) .197
LDL, mean (SD), mmol/L 2.79 (0.93) 2.88 (1.04) 2.89 (1.05) .808
Statin use 153 (75.7) 221 (74.9) 138 (76.7) .850
Aspirin use 182 (90.5) 253 (85.8) 164 (91.1) .945
Oral anticoagulant use 32 (15.9) 41 (13.9) 19 (10.6) .131
Duration of alcohol use, y 49 (8-73) 48 (18-72) .043
Duration of abstention, y 15 (10-55)
BMI, Body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
aData are presented as number (%) or as mean (range), unless otherwise indicated.
bIncluding current smoking.Table II. Plaque characteristics versus alcohol consumption in the femoral and carotid group
Femoral group alcohol consumption Carotid group alcohol consumption
None 1-10 U/wk 10 U/wk None 1-10 U/wk 10 U/wk
Plaque characteristica (n  45) (n  86) (n  93) P (n  210) (n  304) (n  186) P
Lipid core
10% 24 (53.3) 62 (72.1) 75 (80.6) .002 46 (22.1) 64 (21.3) 31 (16.8) .208
10% 21 (46.7) 24 (27.9) 19 (19.4) 162 (77.9) 237 (78.7) 153 (83.2)
Intraplaque thrombus
No thrombus 9 (20.0) 30 (34.9) 24 (25.8) .909 61 (29.3) 79 (26.2) 56 (30.4) .854
Thrombus 36 (80.0) 56 (65.1) 69 (74.2) 147 (70.7) 222 (73.8) 128 (69.6)
Calcifications
None or minor 13 (28.9) 36 (41.9) 22 (23.7) .162 82 (39.4) 137 (45.7) 69 (37.5) .781
Moderate or heavy 32 (71.1) 50 (58.1) 71 (76.3) 126 (60.6) 163 (54.3) 115 (62.5)
Collagen
None or minor 6 (14.0) 7 (8.3) 13 (14.6) .600 39 (18.8) 52 (17.4) 33 (17.9) .802
Moderate or heavy 37 (86.0) 77 (91.7) 76 (85.4) 168 (81.2) 247 (82.6) 151 (82.1)
SMC infiltration
None or minor 9 (20.0) 19 (22.1) 22 (23.9) .604 58 (28.0) 78 (26.0) 61 (33.5) .264
Moderate or heavy 36 (80.0) 67 (77.9) 70 (76.1) 149 (72.0) 222 (74.0) 121 (66.5)
Macrophage infiltration
None or minor 30 (66.7) 62 (73.8) 76 (82.6) .033 81 (39.1) 116 (39.1) 67 (36.4) .594
Moderate or heavy 15 (33.3) 22 (26.2) 16 (17.4) 126 (60.9) 181 (60.9) 117 (63.6)SMC, Smooth muscle cell.
aData are presented as No. (%).
JOURNAL OF VASCULAR SURGERY
July 2011128 Gisbertz et alFig 2. Kaplan-Meier survival estimate shows the comparison of the amount of alcohol consumption with major
cardiovascular events in the (A) femoral study population (P  .010) and in the (B) carotid study population (P 
.618). Dashed lines, none; dashed and dotted lines, 1-10 U/wk; and solid lines, 10 U/wk. SE, Standard error.
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Volume 54, Number 1 Gisbertz et al 129lower extremity arterial occlusive disease and in patients
operated on for cerebrovascular disease. Our results suggest
a protective, dose-related effect of alcohol consumption on
major cardiovascular events and risk of death in patients
with lower extremity arterial occlusive disease. For patients
Table III. A, Primary end point of the femoral cohort
by alcohol consumptiona
None 1-10 U/wk 10 U/wk
Event (n  45) (n  86) (n  93) P
Major cardiovascular
events, % 35 21 10 .010
Cardiovascular
death 14 11 3 .049
Cerebrovascular
death 7 3 0 .015
Myocardial
infarction 9 0 1 .090
CABG 3 0 2 .393
Coronary
angioplasty 6 6 4 .869
Stroke 0 2 0 .201
CABG, Coronary artery bypass grafting.
aKaplan-Meier estimate of event rate after 3 years of follow-up.
Table III. B, Primary end point of the carotid cohort by
alcohol consumptiona
None 1-10 U/wk 10 U/wk
Event (n  210) (n  304) (n  186) P
Major cardiovascular
events, % 11 15 17 .618
Cardiovascular
death 6 4 3 .503
Cerebrovascular
death 1 0 0 .132
Myocardial
infarction 2 1 5 .198
CABG 0 2 3 .318
Coronary
angioplasty 2 6 4 .361
Stroke 4 3 7 .148
CABG, Coronary artery bypass grafting.
aKaplan-Meier estimate of event rate after 3 years of follow-up.
Table IV. Multivariate cox hazard regression analysis for
the femoral study population for major cardiovascular
events
Variable HR (95% CI) P
Sex 1.18 (0.53-2.65) .683
Age 1.03 (0.99-1.07) .126
Rutherford classification 1.04 (0.50-2.18) .920
Ankle-brachial indexa 1.20 (0.58-8.85) .743
Alcohol 0.52 (0.33-0.81) .004
CI, Confidence interval; HR, hazard ratio
aCalculated as blood pressure at ankle level divided by blood pressure at arm
level (mm Hg).with cerebrovascular disease, such a relationship was not fbserved. The lack of a relationship being demonstrated
etween alcohol consumption, plaque composition, and
ardiovascular events could be due to lack of power. How-
ver, with 700 patients in the carotid group, and significant
ariability in plaque types, the carotid cohort was suffi-
iently powered to detect differences between alcohol
roups.
The cardiovascular death rate in the carotid group was
% for 10 U/wk, 5% for 1 to 10 U/wk, and 3% for no
lcohol. This could be interpreted as a trend; however, as
tated before, we believe the carotid cohort was sufficiently
owered to detect differences between alcohol groups. The
therosclerotic plaques of patients in the femoral group
ho abstained from alcohol contained more inflammation
nd larger lipid cores, which are characteristics of vulnera-
le plaques. A linear relation was distinguished between
istologic markers for plaque stability and alcohol con-
umption. Again, in the carotid group, such a difference
as not observed.
Our results are in concordance with previous studies
here alcohol has consistently been associated with a de-
reased risk of clinical manifestations of atherosclerosis.
he effects of alcohol on high-density lipoprotein choles-
erol, fibrinogen, thrombogenicity, and insulin sensitivity
ave been confirmed in randomized trials. These proven
ntiatherosclerotic effects of alcohol suggest that the ob-
erved inverse association between alcohol use and cardio-
ascular events is causal.14-19 Plaque size and intima-media
hickness have been studied in relation to alcohol consump-
ion. In most of these previous studies, however, no corre-
ation was observed between alcohol consumption and the
therosclerotic plaque burden.17,26-30 In addition, calcifi-
ation of coronary and aortic plaques determined by com-
uted tomography scan was not associated with alcohol
onsumption.31-33
A possible explanation for the difference in observed
ffects of alcohol consumption on atherosclerotic disease in
ur study might be that we studied clinical end points and
istologic characteristics of atherosclerotic disease, whereas
he imaging studies focused on the quantitative measures of
therosclerotic disease. Our observed inverse association
etween histologic characteristics of vulnerable plaques and
lcohol consumption suggests that not plaque amount—
ut plaque composition—is influenced by the use of
lcohol.
Previous studies have demonstrated that symptomatic
erebrovascular disease is related to plaques with a large
ipid core and heavy macrophage infiltration.34,35 Why
lcohol is associated with stability of femoral plaques and
ot with characteristics of carotid plaques remains to be
nvestigated. An explanation could be that lower extremity
rterial interventions are generally initiated in a more ad-
anced stage of atherosclerosis than cerebrovascular dis-
ase, with a worse prognosis. Patients presenting with
hronic critical limb ischemia have a 20% mortality rate in
he first year after presentation, whereas the mortality rate
or patients with cerebrovascular disease is 27% at 6 years of
ollow-up.22,36 This is supported by the fact that the event
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July 2011130 Gisbertz et alrate was much lower in all three alcohol groups of the
carotid cohort for both the primary and secondary end
points.
Alcohol might influence the stabilization process dur-
ing aging of the atherosclerotic plaque.We have no data yet
to support this. Our results are consistent with recent
literature, as in a study by Andersen et al,37 alcohol con-
sumption did not affect survival in patients suffering from
stroke. In addition, the vascular biology of femoral athero-
sclerosis may not be identical to carotid artery pathophysi-
ology. It remains unknown, if alcohol intake-sensitive path-
ways potentially might serve a more important role in lower
extremity arterial lesions.
Our study has several potential limitations. Although
multivariate analysis was used to test many possible con-
founders, we cannot exclude the possibility of unknown
residual confounders. Nonetheless, a beneficial effect of
alcohol has also been demonstrated in experimental tri-
als.14,15,18,38
We relied on self-reported alcohol consumption. It is
difficult to exclude a healthy effect bias, because healthy
individuals are more likely to engage in social drinking. How-
ever, unhealthy participants might be under-reporting, sug-
gesting that protective effects could occur at even higher
intake levels than currently assumed.24 We did not asses
alcohol consumption during the follow-up period of 3
years. Theoretically, changes in drinking habits might have
occurred between the carotid and femoral group during
follow-up. However, we concluded this was very unlikely
because all patients routinely received the same advice
regarding alcohol moderation. Furthermore, for change in
alcohol consumption to explain the finding, this change
would need to be related to risk of death and to have
occurred predominantly in the femoral group. Moreover,
at baseline, we assessed changes in drinking behavior in the
past, and there were no differences among the groups (data
not shown).
Careful interpretation of the data is warranted. This was
not a randomized controlled trial and no therapeutic im-
plications can be made from these data. Alcohol consump-
tion also has potential health risks. Alcohol is causally
related to cancers of the oral cavity, esophagus, larynx,
breast, colon, and liver, and also to hypertension, liver
cirrhosis, chronic pancreatitis, injuries and violence, and
cardiomyopathy and arrhythmias.39,40 In this perspective,
abstainers should not be encouraged to consume alcohol,
and patients consuming moderate amounts of alcohol
should not be encouraged to abstain.
CONCLUSION
This study shows an inverse relationship between alco-
hol use and cardiovascular events in patients who undergo
endarterectomy for lower extremity arterial occlusive dis-
ease, but not in patients after endarterectomy for cerebro-
vascular disease. We believe this is the first study to show
that a lower risk for adverse events in patients with lower
extremity arterial occlusive disease who consume alcohol is
accompanied by differences in plaque composition. In theemoral arteries, alcohol abstainers revealed more athero-
atous and inflammatory plaque characteristics, known
ttributes of unstable plaques.
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Ever since attention has been called to the French paradox (eg,
the lower mortality rate for ischemic heart disease in France despite
the high intake in saturated fat), there has been speculation that
alcohol consumption may play a protective role in this epidemio-
logic observation.1 Some of the protective effects of alcohol, and
especially red wine, are thought to include inhibition of low-
density lipoprotein oxidation, increased high-density lipoprotein,
inhibition of smooth muscle cell proliferation, inhibition of plate-
let aggregation, and vasorelaxation.2 It is not currently known
whether the protective effects of red wine are due to the alcohol or
to the complex polyphenols that are contained within it.2
Interestingly, people who drink no alcohol have increased
mortality compared with those people who drink a small amount,
leading to the description of a “J-curve” in mortality.3 It is the
reduced mortality associated with moderate alcohol consumption
(10 to 20 U/wk), the inflection point on the J-curve, that theonsistent with the reported literature; patients undergoing femo-
al endarterectomy who drank no alcohol had increased mortality
nd worse plaque morphology compared with drinkers. However,
here was decreased mortality in patients with higher amounts of
lcohol consumption.
This controversial study raises more questions than it answers:
● Why was the J-curve only partially detected in patients under-
going femoral endarterectomy?
● Does the authors’ assignment of the category of 1 to 10
U/wk reflect the inflection point of the J-curve in this patient
population?
● Does a wider range of alcohol consumption, especially 10 to
20 U/wk compared with lower and higher amounts, need to
be examined?● Why did the authors fail to find a similar effect in patients
undergoing carotid endarterectomy?
